Who is Sergey Brin and why did he donate Alphabet stock?

Sergey Brin is a co-founder of Google. He donated over $1.1 billion in Alphabet stock to fund research into central nervous system diseases and climate change solutions.

What is Catalyst4 and what does it fund?

Catalyst4 is a nonprofit founded by Sergey Brin in 2021. It supports research into central nervous system diseases and climate-change solutions.

How much Alphabet stock did Sergey Brin give away?

Sergey Brin gave away more than $1.1 billion worth of Alphabet Inc. stock, consisting of over 3.5 million shares.

Home / Business and Economy / Google Co-Founder Gifts $1.1B in Alphabet Stock

Google Co-Founder Gifts $1.1B in Alphabet Stock

29 Nov

•

Summary

Sergey Brin donated over $1.1 billion in Alphabet stock.
Most of the donation goes to his nonprofit, Catalyst4.
Catalyst4 supports research into CNS diseases and climate solutions.

Google Co-Founder Gifts $1.1B in Alphabet Stock

Sergey Brin, a co-founder of Google, has recently gifted more than $1.1 billion in Alphabet Inc. stock. This significant contribution was revealed this past Friday through a regulatory filing, detailing the transfer of over 3.5 million shares. The filing did not specify the exact recipients of these shares, but a spokesperson for Brin's family office confirmed the primary beneficiary.

Approximately $1 billion of the stock is designated for Catalyst4, a nonprofit entity that Brin founded in 2021. This organization has a dual mission: to advance research into debilitating central nervous system diseases and to support innovative climate-change solutions. The donation highlights Brin's commitment to philanthropic endeavors through his family office.

This substantial stock donation underscores Brin's dedication to addressing complex global challenges. By channeling such a significant amount through Catalyst4, he is investing in scientific advancements and environmental sustainability. The move positions Catalyst4 to make considerable strides in its targeted research areas, potentially leading to breakthroughs in medicine and climate action.